finanzen.net
18.03.2019 12:30
Bewerten
(0)

Global Neurology Devices Market Outlook to 2024 - Huge Investments by Private Players, Propelling Growth

DRUCKEN

DUBLIN, March 18, 2019 /PRNewswire/ --

The "Neurology Devices Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

The market is projected to grow with a CAGR of 8.41% during the forecast period.

The key factors propelling the growth of the market are the increasing incidence of neurological disorders, huge investments by private players in neurology devices, increase in R&D in the field of neurotherapies, and rising aging population.

The growth of the global neurology devices market is attributed to the increasing incidence of neurological disorders that include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson's disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumor, and stroke.

The increasing healthcare spending, increasing foreign direct investment by global medical device manufactures, and increasing neurological disease prevalence are expected to drive the overall market growth.

Key Market Trends

Sacral Nerve Stimulation Devices Expected to Grow Fastest during the Forecast Period

The sacral nerve stimulation devices are mostly used for patients for whom drug therapy or other types of medications are not successful. It is performed with the help of a small device, which is capable of sending electrical impulses to the targeted sacral nerves located in the lower back region. These devices are found to be successful in treating bladder problems. Hence, with increasing incidences of overactive bladder, the sacral nerve stimulation devices segment is expected to grow during the forecast period.

The deep brain stimulation devices are also being used to perform deep brain stimulation procedures, by implanting a medical device that is capable of sending electrical impulses to specific target areas in the brain. These devices are generally used to treat neuropsychiatric disorders and are effectively used in treating various other neurological disorders, like Parkinson's disease, essential tremor, dystonia, chronic pain, major depression, and obsessive-compulsive disorder.

Asia-Pacific Registered the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period

The Asia-Pacific region is expected to grow, due to the presence of high unmet medical needs, coupled with rapidly rising healthcare R&D investments and growing medical expenditures in emerging economies, such as India and China. There are also a number of government initiatives that are expected to increase over the forecast period.

Competitive Landscape

There are market participants involved in R&D for the development of advanced stimulation and neuromodulation techniques with minimally invasive procedures that are more preferable to the patients. Furthermore, many private companies are showing great interest in developing novel neurological devices to earn huge profits.

Topics Covered

1 Introduction

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Dynamics

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increase in Incidence of Neurological Disorders

4.2.2 Huge Investments by Private Players in Neurology Devices

4.2.3 Increase in R&D in the Field of Neurotherapies

4.2.4 Rise in the Aging Population

4.3 Market Restraints

4.3.1 High Cost of Equipment

4.3.2 Stringent FDA Validation and Guidelines for New Devices

4.4 Porter's Five Forces Analysis

5 Market Segmentation

5.1 By Type of Device

5.1.1 Cerebrospinal Fluid Management Devices

5.1.2 Interventional Neurology Devices

5.1.2.1 Interventional/Surgical Simulators

5.1.2.2 Neurothrombectomy Devices

5.1.2.3 Carotid Artery Stents

5.1.2.4 Embolic Coils

5.1.2.5 Support Devices

5.1.3 Neurosurgery Devices

5.1.3.1 Neuroendoscopes

5.1.3.2 Stereotactic Systems

5.1.3.3 Aneurysm Clips

5.1.3.4 Other Neurosurgery Devices

5.1.4 Neurostimulation Devices

5.1.4.1 Spinal Cord Stimulation Devices

5.1.4.2 Deep Brain Stimulation Devices

5.1.4.3 Sacral Nerve Stimulation Devices

5.1.4.4 Other Neurostimulation Devices

5.1.5 Other Types of Devices

5.2 Geography

5.2.1 North America

5.2.2 Europe

5.2.3 Asia-Pacific

5.2.4 Middle East & Africa

5.2.5 South America

6 Competitive Landscape

6.1 Company Profiles

6.1.1 B. Braun Melsungen AG

6.1.2 Boston Scientific Corporation

6.1.3 Stryker Corporation

6.1.4 Medtronic PLC

6.1.5 Abbott Laboratories

6.1.6 Johnson and Johnson

6.1.7 Smith & Nephew

6.1.8 MicroPort Scientific Corporation

6.1.9 Nihon Kohden Corporation

6.1.10 Penumbra Inc.

7 Market Opportunities and Future Trends


For more information about this report visit

https://www.researchandmarkets.com/research/xjgl5q/global_neurology?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-neurology-devices-market-outlook-to-2024---huge-investments-by-private-players-propelling-growth-300813805.html

SOURCE Research and Markets

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX schließt höher -- US-Börsen schwächer -- Softbank steigt bei Wirecard ein -- Deutsche Bank spricht wohl mit UBS über Fusion der Vermögensverwaltung -- Boeing, Snap, eBay, SAP im Fokus

Exxon investiert über eine Milliarde Dollar in Ausbau britischer Raffinerie. Eni verfehlt mit operativem Gewinn die Markterwartung. Bieterwettkampf um Anadarko - Occidental bietet 57 Milliarden Dollar. Five-Eye-Staaten schließen Huawei von Kern-Netzwerken aus. AT&T wächst nur dank Time-Warner-Zukauf. Biogen wächst deutlich.

Die 5 beliebtesten Top-Rankings

Die beliebtesten Arbeitgeber in Deutschland
Hier gibt es die beliebtesten Jobs
Die zehn größten Kapitalvernichter
Hier wurde am meisten Anlegergeld verbrannt
DIe innovativsten Unternehmen
Diese Unternehmen sind am fortschrittlichsten
Das hat sich geändert
Diese Aktien hat George Soros im Depot
Diese Aktien hat Warren Buffett im Depot
Einige Änderungen unter den Top-Positionen
mehr Top Rankings

Umfrage

Der Bitcoin konnte wieder über die Marke von 5.500 Dollar klettern. Wo sehen Sie den Kurs der Kryptowährung Ende 2019?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
SAP SE716460
Daimler AG710000
Amazon906866
Deutsche Bank AG514000
CommerzbankCBK100
BayerBAY001
Apple Inc.865985
TeslaA1CX3T
BASFBASF11
E.ON SEENAG99
Allianz840400
Aurora Cannabis IncA12GS7
Volkswagen (VW) AG Vz.766403
Deutsche Telekom AG555750